Cerebral Ischemia Clinical Trial
— RIPHeartOfficial title:
Organ Protection by Remote Ischemic Preconditioning for Surgical Treatment of Pediatric Congenital Heart Disease
Verified date | October 2016 |
Source | University of Schleswig-Holstein |
Contact | n/a |
Is FDA regulated | No |
Health authority | Germany: Ethics Commission |
Study type | Interventional |
Cardiac surgery is associated with risk of perioperative inflammation and ischemia leading to cerebral and myocardial morbidity and mortality. Ischemic preconditioning by repetitive ischemic episodes at an organ can reduce damage resulting from consecutive prolonged ischemia in that organ. Remote ischemic preconditioning is defined as ischemic preconditioning by repetitive ischemic episodes of an organ remote from the organ to be protected, e.g. ischemic episodes of a limb can reduce ischemic damage of the heart. Animal studies as well as human studies have shown that ischemic preconditioning can protect the heart from intraoperative ischemia. Remote preconditioning by repetitive limb ischemia has been applied in humans in some studies.12-14 However, the published data is not yet sufficient to support evidence based recommendations for clinical practice. In particular, available data regarding the influence of remote preconditioning on inflammatory and ischemic damage of brain and heart in children following surgery of congenital heart disease are limited. Hence, this prospective, controlled and randomized study was designed to perform remote ischemic preconditioning in children after induction of anesthesia for pediatric heart surgery and to investigate the effect on postoperative organ function in comparison to a control group.
Status | Terminated |
Enrollment | 31 |
Est. completion date | May 2014 |
Est. primary completion date | March 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 16 Years |
Eligibility |
Inclusion Criteria: - congenital heart surgery Exclusion Criteria: - hypoplastic left heart syndrome |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Germany | University Hospital Schleswig-Holstein, Campus Kiel | Kiel | Schleswig-Holstein |
Lead Sponsor | Collaborator |
---|---|
University of Schleswig-Holstein |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | serum troponin T | Serum troponin T is measured 8, 16 and 24 hours after end of surgery. Values of serum troponin T are compared between remote ischemic preconditioning group and control group. | 48 hours | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT04167527 -
Endovascular Therapy for Low NIHSS Ischemic Strokes
|
Phase 2/Phase 3 | |
Recruiting |
NCT04583163 -
Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
|
||
Completed |
NCT01436812 -
Effect of Positive End Expiratory Pressure (PEEP) on Cerebral Oxymetry During Laparoscopy
|
N/A | |
Terminated |
NCT00141011 -
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
|
Phase 3 | |
Recruiting |
NCT05053932 -
Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia
|
||
Completed |
NCT04437862 -
A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke
|
N/A | |
Completed |
NCT00598819 -
A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00207961 -
The Threshold Value of Regional Cerebral Oxygenation in Detecting Cerebral Ischemia
|
N/A | |
Not yet recruiting |
NCT04696523 -
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
|
Phase 2 | |
Completed |
NCT02351518 -
Cerebral Autoregulation and Vasospasm in Patients With TBI
|
||
Completed |
NCT01546636 -
The Effect of Ventilation on Cerebral Oxygenation in the Sitting Position
|
N/A | |
Completed |
NCT04047563 -
Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
|
Phase 3 | |
Completed |
NCT05087836 -
Correlation of Cerebral Oxygen Saturation Measured From 2 Sensor Sites: Forehead vs. Temporal
|
||
Completed |
NCT02448069 -
Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
|
Phase 2 | |
Completed |
NCT02147275 -
Monitoring Hypertensive Patients's Cerebral Oxygen Saturation
|
N/A | |
Completed |
NCT01875055 -
Reversing Cerebral Oxygen Desaturations Greater That 10% of Baseline Values Using NIRS in the ICU
|
N/A | |
Completed |
NCT02389647 -
Identification of Novel Molecular Markers for Cerebral Ischemia From Patients With Minor and Devastating Ischemic Injury
|
||
Completed |
NCT02643030 -
Hypercapnia During Shoulder Arthroscopy
|
N/A | |
Completed |
NCT01436799 -
Desflurane Versus Propofol in the Sitting Position
|
N/A |